Ozdemir Hatice, Akinci Emine, Coskun Figen
Senlik Mahallesi, Baldiran Sokak, 40/18 06310 Kecioren, Ankara, Turkey.
Singapore Med J. 2013 Nov;54(11):649-52. doi: 10.11622/smedj.2013225.
We aimed to compare the effectiveness of intravenous piracetam with that of intravenous dimenhydrinate in the treatment of acute peripheral vertigo in the emergency department.
This double-blind study comprised a total of 200 patients, aged between 18 and 70 years, who had presented to the emergency department of Ankara Training and Research Hospital and were diagnosed with peripheral vertigo. Evaluation of the severity of the patients' vertigo was performed using a visual analogue scale, before and after drug administration.
Both drugs were found to be effective (p < 0.001) and had comparable effects (p < 0.474). Dimenhydrinate was also found to have about two times the side effects of piracetam. Drowsiness was found to be the most common side effect of these two drugs.
Dimenhydrinate and piracetam have similar levels of effectiveness with regard to acute vertigo. We conclude that piracetam, which has fewer side effects than dimenhydrinate, better vestibular compensation, and is effective for both acute and chronic vertigo, could be more frequently used in the emergency treatment of acute vertigo.
我们旨在比较静脉注射吡拉西坦与静脉注射茶苯海明在急诊科治疗急性周围性眩晕的疗效。
这项双盲研究共纳入200例年龄在18至70岁之间、到安卡拉培训与研究医院急诊科就诊并被诊断为周围性眩晕的患者。在给药前后,使用视觉模拟量表对患者眩晕的严重程度进行评估。
两种药物均被发现有效(p < 0.001)且效果相当(p < 0.474)。还发现茶苯海明的副作用约为吡拉西坦的两倍。嗜睡是这两种药物最常见的副作用。
茶苯海明和吡拉西坦在急性眩晕方面的疗效水平相似。我们得出结论,吡拉西坦副作用比茶苯海明少,具有更好的前庭代偿作用,且对急性和慢性眩晕均有效,在急性眩晕的急诊治疗中可更频繁地使用。